Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?

Considering the limited progress of chemotherapy and targeted therapy in improving the generally disappointing outcomes of advanced gastric or gastroesophageal junction cancer (GC/GEJC), immunotherapies have been gradually developed and advanced into novel frontiers of treatment for advanced GC/GEJC...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Rilan, Chen, Naifei, Liang, Tingting, Li, Lingyu, Lv, Zheng, Lv, Xiaomin, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386300/
https://www.ncbi.nlm.nih.gov/pubmed/32793461
http://dx.doi.org/10.3389/fonc.2020.00912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386300/
https://www.ncbi.nlm.nih.gov/pubmed/32793461
http://dx.doi.org/10.3389/fonc.2020.00912

Ejemplares similares